A market bloated on F&O speculation has slimmed under Sebi watch - 20% leaner
Record orders and rising profitability show the network is hitting full stride
Following a record-setting week, the initial public offering (IPO) market is expected to pause, with only one issue - Midwest - scheduled for the coming week.
Extended gaps in board appointments raise concerns over continuity, policy direction, and adjudication at the capital markets regulator
Shares dip after Q2 profit misses estimates; brokerages cite solid AI plans and margin gains but flag weak near-term growth visibility
Tata Capital and LG Electronics India are among the key names set to debut on the exchanges, alongside Canara Robeco Asset Management, Rubicon Research, and Canara HSBC Life Insurance
Religare Broking's Ajit Mishra continues to maintain a 'buy on dips' strategy and recommends focusing on opportunities with a favourable risk-reward setup
Midwest IPO comprises a fresh issue of 2.3 million equity shares and an offer for sale of 1.9 million equity shares
Citi said that it prefers execution leaders exposed to key thematics, with Cummins India and Bharat Electronics as its top picks
Systematix values the Inox India stock at 48x FY27E EPS of ₹34.09 per share and arrives at a target price of ₹1,636
Analysts said TCS delivered a strong performance in Q2 despite prevailing challenges, with the India business continuing to show robust growth
5paisa Capital shares have fallen 18 per cent this year, compared to a 6.7 per cent advance in the benchmark Nifty 50
Indian Rupee today: The domestic currency opened flat at 88.78 against the greenback on Friday, according to Bloomberg
Stocks to Watch today, October 10, 2025: From TCS, Tata Elxsi to NTPC Green Energy, here is a list of stocks that will be in focus
BFSI and Hi-tech segments are expected to perform better for HCL Tech, while manufacturing is likely to remain under pressure
The existing SIP (Systematic Investment Plan) and STP (Systematic Transfer Plan) in Kotak Silver ETF Fund of Fund will however remain active
Early product launches and reliable aftermarket support make the company a market leader
Among major gainers, Aurobindo Pharma led the rally, surging 4.49 per cent to Rs 1,118.9, followed by Lupin, which climbed 2.73 per cent to Rs 1,957.6
Trend could act as 'safety valve' for Indian market and prevent excessive valuation, says one analyst
The company aims to grow its revenue from these businesses to 30.94 billion rupees by fiscal year 2027